Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | GILD | BMY | ||
| Company | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 461.34 | 121.13 | 56.17 | ||
| High | 461.34 | 121.13 | 56.17 | ||
| Low | 461.34 | 121.13 | 56.17 | ||
| Latest | 458.86 | 120.47 | 56.25 | ||
| Change | -5.00 | -0.63 | +0.39 | ||
| % Change | -1.08% | -0.52% | +0.70% | ||
| Volume | 2,641 | 13,211 | 17,522 | ||
| 20-Day Average Volume | 1,297,622 | 6,095,980 | 14,866,481 | ||
| Previous Close | 463.86 | 121.10 | 55.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 458.82 | 122.26 | 54.41 | ||
| 20-Day Raw Stochastic | 41.04% | 40.36% | 83.87% | ||
| 20-Day Relative Strength | 55.28 | 48.17 | 65.88 | ||
| Weighted Alpha | +10.85 | +26.73 | +9.07 | ||
| Today's Opinion | 88% Buy | 40% Buy | 88% Buy | ||
| Previous Opinion | 88% Buy | 40% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 72% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.79% since 01/05/26 | +2.39% since 01/05/26 | +5.86% since 01/05/26 | ||
| Low | 453.69 on 01/06/26 | 118.22 on 01/06/26 | 53.15 on 01/06/26 | ||
| High | 487.52 on 01/07/26 | 125.11 on 01/08/26 | 56.97 on 01/08/26 | ||
| 1-Month | |||||
| %Chg | +2.06% since 12/12/25 | +0.61% since 12/12/25 | +7.17% since 12/12/25 | ||
| Low | 443.12 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 | ||
| High | 487.52 on 01/07/26 | 127.41 on 12/23/25 | 56.97 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | +13.13% since 10/10/25 | +3.37% since 10/10/25 | +27.78% since 10/10/25 | ||
| Low | 402.58 on 10/13/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 | ||
| High | 487.52 on 01/07/26 | 128.70 on 11/20/25 | 56.97 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | -1.60% since 07/11/25 | +10.48% since 07/11/25 | +19.87% since 07/11/25 | ||
| Low | 362.50 on 08/11/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 | ||
| High | 487.52 on 01/07/26 | 128.70 on 11/20/25 | 56.97 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 117,690,088 | 150,246,352 | 113,717,168 | ||
| Shares Outstanding, K | 253,719 | 1,240,680 | 2,035,753 | ||
| Annual Sales | 11,020,100,000 | 28,754,000,000 | 48,300,000,000 | ||
| Annual Net Income | -535,600,000 | 480,000,000 | -8,948,000,000 | ||
| Last Quarter Sales | 3,076,400,000 | 7,769,000,000 | 12,222,000,000 | ||
| Last Quarter Net Income | 1,082,900,000 | 3,052,000,000 | 2,201,000,000 | ||
| 60-Month Beta | 0.31 | 0.33 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.80 on 11/03/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 | ||
| Latest Earnings Date | 02/09/26 | 02/10/26 | 02/05/26 | ||
| Most Recent Dividend | N/A | 0.790 on 12/15/25 | 0.630 on 01/02/26 | ||
| Next Ex-Dividends Date | N/A | 12/15/25 | 01/02/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 30.30 | 14.79 | 8.52 | ||